Urea and atherosclerosis-evidence for a direct link involving apolipoprotein B protein modifications

被引：4
作者：
Albert, Christian [1 ]
Mertens, Peter R. [1 ]
Bartsch, Peter [1 ]
机构：
[1] Otto VonGuericke Univ Magdegurg, Dept Hypertens & Nephrol, D-39120 Magdeburg, Germany
来源：
INTERNATIONAL UROLOGY AND NEPHROLOGY | 2011年 / 43卷 / 03期
关键词：
KIDNEY-DISEASE; UREMIA; CARBAMYLATION; LDL;
D O I：
10.1007/s11255-011-9990-1
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：933 / 936
页数：4
相关论文
共 12 条
[1]   Quantification of carbamylated LDL in human sera by a new sandwich ELISA [J].
Apostolov, EO ;
Shah, SV ;
Ok, E ;
Basnakian, AG .
CLINICAL CHEMISTRY, 2005, 51 (04) :719-728
[2]   Chronic Uremia Stimulates LDL Carbamylation and Atherosclerosis [J].
Apostolov, Eugene O. ;
Ray, Debarti ;
Savenka, Alena V. ;
Shah, Sudhir V. ;
Basnakian, Alexei G. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (11) :1852-1857
[3]   Carbamylated proteins and peptides in health and in uremia [J].
Berlyne, GM .
NEPHRON, 1998, 79 (02) :125-130
[4]   Carbamylated hemoglobin: A potential marker for the adequacy of hemodialysis therapy in end-stage renal failure [J].
Davenport, A ;
Jones, S ;
Goel, S ;
Astley, JP ;
Feest, TG .
KIDNEY INTERNATIONAL, 1996, 50 (04) :1344-1351
[5]   Accumulation of cyanide and thiocyanate in haemodialysis patients [J].
Hasuike, Y ;
Nakanishi, T ;
Moriguchi, R ;
Otaki, Y ;
Nanami, M ;
Hama, Y ;
Naka, M ;
Miyagawa, K ;
Izumi, M ;
Takamitsu, Y .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (06) :1474-1479
[6]   Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions [J].
Kanbay, Mehmet ;
Ozkara, Adem ;
Selcoki, Yusuf ;
Isik, Bunyamin ;
Turgut, Faruk ;
Bavbek, Nuket ;
Uz, Ebru ;
Akcay, Ali ;
Yigitoglu, Ramazan ;
Covic, Adrian .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2007, 39 (04) :1227-1233
[7]   Lipid and lipoprotein ratios as risk factors of atherosclerosis in patients with chronic renal insufficiency (CRI) [J].
Kimak E. ;
Solski J. ;
Janicka L. ;
Zagojska M. .
International Urology and Nephrology, 1999, 31 (2) :263-267
[8]   Vitamin D and cardiovascular risk [J].
Mertens, P. R. ;
Mueller, R. .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2010, 42 (01) :165-171
[9]  
Navab KD, 2011, CURR PHARM DESIGN, V17, P17
[10]   Myeloperoxidase and cardiovascular disease [J].
Nicholls, SJ ;
Hazen, SL .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (06) :1102-1111
12